Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by Yunnan AIDS Care Center.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
Yunnan AIDS Care Center
ClinicalTrials.gov Identifier:
NCT01318096
First received: March 8, 2011
Last updated: March 17, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: September 2013
  Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)